The Commonwealth, state and territory governments across Australia are increasing their focus on improving the safety and quality of end-of-life care.
Found 316 result(s)
Gastroscopy is used to investigate, treat and monitor some gastrointestinal conditions. Find out about variation in repeat gastroscopy services in the Fourth Australian Atlas of Healthcare Variation 2021.
The Commission is working in partnership with The George Institute for Global Health and Sepsis Australia to extend the National Sepsis Program. This program aims to improve the awareness, recognition and support for people at risk of or diagnosed with sepsis in Australia.
Information about the Delirium Clinical Care Standard for clinicians
Guidance for clinicians on the ten quality statements from the COPD Clinical Care Standard, as well as helpful resources.
Indicators have been developed to support monitoring of the care recommended in the Delirium Clinical Care Standard. Clinicians and health service organisations can use the indicators to support local quality improvement activities.
Healthcare rights and informed consent
Quality statement 1 - Cataract Clinical Care Standard
A patient with visual problems and suspected cataract has an initial assessment in primary care of their visual impairment, vision-related activity limitations, comorbidities and willingness to have surgery. When referral is appropriate based on these criteria, the patient is referred for consideration for cataract surgery, and this information is included in the referral form.
Analgesic prescribing for a patient with acute pain is guided by its expected severity and assessment of patient-reported pain intensity and the impact of pain on the patient’s function.
Quality statement 1
A patient with any key risk factor for delirium is identified on presentation and a validated tool is used to screen for cognitive impairment, or obtain a current score if they have known cognitive impairment. Before any planned admission, the risk of delirium is assessed and discussed with the patient, to enable an informed decision about the benefits and risks.
The Third Australian Atlas of Healthcare Variation investigates healthcare use in four clinical areas. Neck ultrasound and thyroidectomy are included in Chapter 3, Thyroid investigations and treatments.
Digital mental health service providers have a responsibility to the community for continuous improvement of the safety and quality of their services, and ensuring that they are person centred, safe and effective.
A patient, their family or carer is informed about sepsis from the time that it is suspected in a way that they can understand. Information includes the expected treatment and potential health effects of sepsis. Information is provided verbally and in writing.
Several overarching themes have emerged from the Atlas series: the need for regular public reporting, access to more complete and informative data, quality improvement strategies for the use of tests, and better information for consumers to allow informed decision‑making.
Quality statement 2
A patient at risk of delirium is offered a set of interventions to prevent delirium and is regularly monitored for changes in behaviour, cognition and physical condition. Appropriate interventions are determined before a planned admission or on admission to hospital, in discussion with the patient and their family or carer.
The Third Australian Atlas of Healthcare Variation investigates healthcare use in four clinical areas. Proton pump inhibitor medicines dispensing in infants is included in Chapter 1 on neonatal and paediatric health.
These FAQs answer some common questions about the Comprehensive Care Standard, and more generally what comprehensive care means in the Australian health system.
Quality statement 1
During the antenatal period, a woman is informed about the risk of a third or fourth degree perineal tear. Throughout pregnancy, labour and birth, she is supported to make decisions and provide informed consent for the care she receives.
A number of resources have been identified which are relevant to the Psychotropic Medicines in Cognitive Disability or Impairment Clinical Care Standard.